How a Publicly Traded Gene Therapy Company Optimized  Construct Design with FORMsight^AI

While cell and gene therapies have the potential to save lives and revolutionize medicine, the trial-and-error manufacturing process can consume valuable time and capital, creating significant risks for companies. 

In this case study you'll learn about:

• The common challenges in rAAV modeling and production
• The economic drivers pointing to the need for manufacturing optimized design
• How FORMsight^AI predictively reduced the truncations that impact development cost and time-to-market

Download today. 

Complete the form and you'll receive a PDF of the case study.